Hotline 24/7: 0909384389

Share links:

Alirocumab receives EC approval in established atherosclerotic cardiovascular disease

Ngày 03/04/2019 07:41 | Lượt xem: 1676

The European Commission (EC) has approved the use of alirocumab (Praluent, Sanofi), a PCSK9 inhibitor, in adults with established atherosclerotic cardiovascular disease (ASCVD) to lower low-density lipoprotein cholesterol (LDL-C) levels, reducing cardiovascular risk.
Approximately seven million people have cardiovascular disease in the UK, with 160,000 deaths annually. Atherosclerotic cardiovascular disease can lead to a number of serious conditions such as stroke, peripheral artery disease and acute coronary syndrome (ACS).
The approval is based on data from the ODYSSEY OUTCOMES trial which assessed the effect of alirocumab in 18,924 people who had an acute coronary syndrome between one and 12 months before enrolling in the trial and who were already on intensive or maximally-tolerated statin treatment. The data, published in the New England Journal of Medicine, found that alirocumab significantly reduced the risk of major adverse cardiovascular events (MACE) by 15% (hazard ratio [HR] 0.85;95% confidence interval [CI] 0.78–0.93; p<0001) compared to placebo. The primary endpoint was a composite of death from coronary heart disease, nonfatal myocardial infarction, fatal or nonfatal ischemic stroke, or unstable angina requiring hospitalisation. The safety profile in ODYSSEY OUTCOMES was consistent with the overall safety profile described with the previous phase III controlled trials.
ODYSSEY OUTCOMES UK principal investigator Professor Kausik Ray (Department of Public Health and Primary Care, Imperial College London,UK) said: “Cardiovascular disease is one of the UK’s biggest killers and one in four people will die early as a result. There is a need for additional treatment options for those who can’t use or tolerate statins, or for whom statins are not enough to bring their cholesterol levels within the recommended range. The ODYSSEY OUTCOMES trial showed that using alirocumab to lower cholesterol can reduce the number of people who are at high risk of having another cardiovascular event. This is good news for patients and, as clinicians, we must do everything we can to ensure the right patients get access to this treatment at the right time.”

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support